Log In
Print
BCIQ
Print
Print this Print this
 

Nurelin, amantadine (ADS-5102)

  Manage Alerts
Collapse Summary General Information
Company Adamas Pharmaceuticals Inc.
DescriptionOral extended-release formulation of amantadine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today